Walgreens Stock Falls Over 3% In Premarket As Wall Street Veterans Debate Private Equity Deal Value Amid Sycamore Takeover Talks
Walgreens Stock Falls Over 3% In Premarket As Wall Street Veterans Debate Private Equity Deal Value Amid Sycamore Takeover Talks
$WBA +20% to $10.70 on reports that private equity firm Sycamore Partners is in talks to take Walgreens private. My back-of-the-envelope math suggests a $15/share ($13B total) bid could be on the table, which assumes a paltry 6x EV/EBITDA deal price (equates to 16.6% pretax cash...Walgreens Boots Alliance Inc. (NASDAQ:WBA) retreated 3.26% to $10.08 in Wednesday's pre-market trading, following Tuesday's 20% surge, as prominent market voices weighed in on the potential private takeover by Sycamore Partners.
沃爾格林靴業聯盟公司（納斯達克股票代碼：WBA）在週三的盤前交易中下跌3.26％，至10.08美元，此前週二上漲了20％，原因是知名市場人士對Sycamore Partners可能進行的私人收購進行了權衡。
What Happened: Gary Black, Managing Partner at The Future Fund LLC, outlined a detailed valuation case for a possible $15 per share offer.
發生了什麼：未來基金有限責任公司管理合夥人加里·布萊克概述了可能的每股15美元要約的詳細估值案例。
Walgreens management guided for the fiscal year 2025, expecting adjusted earnings per share to range between $1.40 and $1.80 during their most recent earnings call. At the current stock price of $10.70, this places WBA's price-to-earnings ratio at 6.7 times the fiscal year 2025 EPS, Black wrote on X, noting that the stock currently offers a 9.3% dividend yield.
沃爾格林管理層對2025財年的指導，在最近的業績電話會議上，預計調整後的每股收益將在1.40美元至1.80美元之間。布萊克在X上寫道，按照目前的10.70美元的股價，這使WBA的市盈率達到2025財年每股收益的6.7倍，並指出該股目前的股息收益率爲9.3％。
$WBA +20% to $10.70 on reports that private equity firm Sycamore Partners is in talks to take Walgreens private. My back-of-the-envelope math suggests a $15/share ($13B total) bid could be on the table, which assumes a paltry 6x EV/EBITDA deal price (equates to 16.6% pretax cash...
— Gary Black (@garyblack00) December 10, 2024
有報道稱私募股權投資公司Sycamore Partners正在談判將沃爾格林私有化，WBA上漲20％，至10.70美元。我的粗略數學表明，每股15美元（總額爲130億美元）的出價可能擺在桌面上，假設電動汽車/息稅折舊攤銷前利潤的交易價格微不足道的6倍（相當於16.6％的稅前現金...
— 加里·布萊克 (@garyblack00) 2024 年 12 月 10 日
CNBC's Jim Cramer struck a more cautious tone, warning investors about the deal's complexity. "Wow, Walgreen's too tough to turn even for the great Wentworth whom I revere. Don't overpay for this one..." Cramer posted on X.
CNBC的吉姆·克萊默採取了更爲謹慎的態度，警告投資者注意這筆交易的複雜性。「哇，即使對於我崇拜的偉大溫特沃斯來說，沃爾格林也太難轉身了。不要爲這個多付錢...」克萊默在 X 上發帖
Wow, Walgreen's too tough to turn even for the great Wentworth whom i revere. Don't overpay for this one...
— Jim Cramer (@jimcramer) December 10, 2024
哇，即使對於我敬佩的偉大溫特沃斯來說，沃爾格林也太難轉身了。不要爲這個多付錢...
— 吉姆·克萊默 (@jimcramer) 2024 年 12 月 10 日
What Happened: The commentary comes amid Walgreens' stark decline from its December 2015 peak of $85 per share, when it commanded a $100 billion market value. The pharmacy chain, now valued at roughly $9 billion, has lost 82% of its value since 2020 as it faces growing competition from online pharmacies and Amazon.com Inc.
發生了什麼：該評論是在沃爾格林從2015年12月每股85美元的峯值大幅下跌之際發表的，當時其市值爲1000億美元。由於面臨來自在線藥房和亞馬遜公司的日益激烈的競爭，這家連鎖藥房目前的價值約爲90億美元，自2020年以來已經損失了82％的價值。
The Wall Street Journal reported that Sycamore Partners, which previously acquired Staples for $7 billion in 2017, might seek partners or divest certain assets if a deal materializes. This approach differs from KKR's failed 2019 bid of approximately $70 billion, which Walgreens' board rejected as insufficient.
《華爾街日報》報道說，Sycamore Partners此前曾在2017年以70億美元的價格收購斯台普斯，如果交易得以實現，可能會尋找合作伙伴或剝離某些資產。這種方法不同於KKR在2019年失敗的約700億美元的出價，沃爾格林董事會以不足爲由拒絕了該出價。
Walgreens' recent struggles are evident in its latest quarterly results, where adjusted earnings dropped 41% despite revenue growth, leading to plans for closing 1,200 stores over three years.
沃爾格林最近的困境在其最新的季度業績中顯而易見，儘管收入增長，調整後的收益仍下降了41％，導致計劃在三年內關閉1,200家門店。
- Robotaxi Exit To 'Clear The Way' For GM To License Tesla FSD, Says Gary Black — Move Will Save The Mary Barra-Led Company $1B A Year
- 加里·布萊克說，退出Robotaxi將爲通用汽車向特斯拉FSD發放許可 「掃清道路」 ——此舉將爲這家由瑪麗·巴拉領導的公司每年節省10億美元
Image via Unsplash
圖片來自 Unsplash
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：該內容部分是在人工智能工具的幫助下製作的，並由Benzinga編輯審查和發佈。
